Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 147 (4) , 1497-1501.e1
Abstract
No abstract availableKeywords
Funding Information
- Division of Intramural Research
This publication has 18 references indexed in Scilit:
- Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy numberNature Genetics, 2016
- Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical ImmunologyJournal of Allergy and Clinical Immunology, 2016
- Mast Cells, Mastocytosis, and Related DisordersNew England Journal of Medicine, 2015
- Molecular Defects in MastocytosisImmunology and Allergy Clinics of North America, 2014
- Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalitiesJournal of Allergy and Clinical Immunology, 2014
- International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosisBlood, 2013
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus ProposalInternational Archives of Allergy and Immunology, 2011
- Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestationsJournal of Allergy and Clinical Immunology, 2011
- Mast cell activation syndrome: Proposed diagnostic criteriaJournal of Allergy and Clinical Immunology, 2010